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SUMMARY 
Antimicrobial resistance (AMR) is a fast growing problem throughout the world, and as a 
consequence effective treatment of various infections is jeopardized. This results in prolonged 
illness and increased mortality amongst patients as well as increased health care costs. It is 
known that excessive usage of antimicrobial drugs contributes to the development of 
antimicrobial resistance. There have also been reports of resistant bacteria spreading from 
animals to human. However, the full magnitude of the problem worldwide is still not known. 
In a joint effort to combat AMR, the Food and Agricultural Organization of the United 
Nations (FAO), the World Health Organization (WHO) and the World Organization for 
Animal Health (OIE) therefore encourages countries to develop harmonized AMR-monitoring 
programs to map the AMR in food animals. 
The pig industry in Southeast Asia has been steadily growing the last decades; however the 
knowledge about the occurrence of AMR is poor. In Thailand there have been studies that 
map AMR in pigs; however there is a lack of standardization and harmonization, which 
makes national data difficult to interpret. 
The purpose of this study was to investigate the occurrence of antimicrobial resistance in 
small-scale swine herds in Khon Kaen Province in the northeast of Thailand, using intestinal 
Escherichia coli as indicator bacteria. Furthermore the purpose was also to compare the result 
from this study with data from similar studies from Thailand and other countries. 
Twenty-five farms were visited, which housed a maximum of twenty sows each. To help gain 
insight in pig farming in Thailand and help identify possible factors affecting AMR, the 
person responsible for the pigs at each farm was asked to fill in a questionnaire with questions 
about the farm, husbandry, antibiotic usage, vaccination regimes etc. 
On each farm three samples were collected in the form of rectal swabs from three different 
healthy sows. A total of 69 samples were collected. From each sample E. coli was cultured 
and tested for antimicrobial susceptibility using a standardized broth microdilution method to 
determine minimum inhibitory concentrations (MICs).  
Resistant isolates of E. coli was found on all farms. Resistance against tetracycline (75.3% of 
the isolates), ampicillin (69.6%) and sulfamethoxazole (60.8%) were the most common. 
Multiresistance could be seen in 69.5% of the isolates. One suspected extended spectrum 
beta-lactamase producing (ESBL)-isolate was found. Statistical analyses to identify risk 
factors for AMR were difficult to perform due to the small number of observations and those 
made must therefore be considered to lack in statistical power. 
When compared to OECD countries the level of AMR was generally higher in this study. 
When compared to studies from Thailand made on larger farms, the AMR levels were 
generally lower in this study. 
   
 
 
 
Antimicrobial resistance seems to be common in small-scale swineherds in north-eastern 
Thailand. However, a national standardized and harmonized monitoring program is needed to 
fully evaluate the situation. 
  
   
 
 
 
SAMMANFATTNING 
Antimikrobiell resistens (AMR) är ett problem som växer snabbt runt om i världen. Som en 
konsekvens av detta ökar risken att olika infektioner inte längre går att behandla effektivt. 
Detta resulterar i förlängd sjukdomstid och ökat antal dödsfall samt ökade kostnader för 
sjukvård. Det är känt att överdriven användning av antimikrobiella läkemedel bidrar till 
utvecklingen av antimikrobiell resistens. Det finns även rapporter om resistenta bakterier som 
sprider sig från djur till människor. Dock är det ännu inte klarlagt hur stort problemet är 
globalt. Med målsättning att motverka AMR, har Förenta nationernas livsmedels- och 
jordbruksorganisation (FAO), Världshälsoorganisationen (WHO) och Världsorganisationen 
för djurhälsa (OIE) gått samman i frågan och uppmuntrar därför länder att utveckla och införa 
standardiserade AMR-övervakningsprogram för livsmedelsproducerande djur. 
Grisindustrin i sydöstra Asien har växt under de senaste decennierna. Dessvärre är kunskapen 
om utbredningen av AMR dålig. I Thailand har studier som kartlägger AMR gjorts på grisar, 
men då standardiserade metoder inte använts är den nationella datan svårtolkad. 
Syftet med denna studie var att undersöka förekomsten av AMR i små grisbesättningar i Khon 
Kaen-provinsen i nordöstra Thailand, genom att använda Escherichia coli i tarmen som 
indikatorbakterie. Vidare var syftet att jämföra resultaten från denna studie med data från 
liknande studier från Thailand och andra länder. 
Tjugofem gårdar med max tjugo suggor vardera besöktes. För att få ökad insikt i 
grisproduktion i Thailand och för att kunna finna möjliga faktorer som påverkar AMR fick 
ansvarig person på gården fylla i ett frågeformulär. Detta innehöll frågor rörande gården, 
skötseln, antibiotikaanvändning, vaccinationsrutiner etc. 
På varje gård togs tre prov i form av rektalsvabbar från tre olika friska suggor. Totalt 
samlades 69 prover in. Från varje prov isolerades E. coli och därefter undersöktes isolatens 
känslighet för olika antibiotika. Detta gjordes genom att använda en standardiserad buljong-
mikrodilutionsmetod för att bestämma MIC (minimum inhibitory concentration). 
Resistenta isolat av E. coli sågs på alla gårdar. Resistens mot tetracyklin (75,3 % av isolaten), 
ampicillin (69,6 %)  och sulfamethoxazole (60,8 %) var vanligast. Multiresistens sågs hos 
69,5 % av isolaten. Ett misstänkt ESBL(extended spectrum beta-lactamase)-producerande 
isolat hittades. Statistiska analyser för att indentifiera riskfaktorer för AMR var svåra att 
genomföra då antalet observationer i de flesta fall var för få. De analyser som gjorts måste 
därmed anses sakna statistisk ”power”. 
Jämfört med OECD-länder var förekomsten av AMR generellt sett högre i denna studie. Vid 
jämförelse med andra studier från Thailand utförda på större gårdar, var förekomsten av AMR 
generellt sett lägre i denna studie. 
   
 
 
 
Sammantaget tycks antimikrobiell resistens vara vanligt förekommande i små grisbesättningar 
i nordöstra Thailand. Det behövs emellertid ett nationellt standardiserat övervakningsprogram 
för att fullt ut kunna utvärdera situationen. 
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INTRODUCTION AND LITTERATURE REVIEW  
Antimicrobial resistance (AMR) throughout the world is a problem which has been growing 
for several decades. It is, according to the World Health Organization (WHO), a problem so 
severe that it threatens the achievements of modern medicine. As the problem grows, the 
effective treatment of various infections is jeopardized. Although the magnitude of the 
problem worldwide is still largely unknown, it is clear that AMR might lead to prolonged 
illness and increased mortality in patients, as well as increased health care costs (WHO, 
2014). 
In a report in 2013, WHO estimated that hospital-acquired infections with multiresistant 
bacteria annually causes the death of around 30 000 people in Thailand, 25 000 people in the 
European Union, 23 000 people in the United States of America and 80 000 people in China. 
In addition, it is estimated that the cost due to these antibiotic-resistant infection is 2000 
million USD in the US and 1500 million EUR in the EU (WHO, 2013). 
Chantziaras et al., (2013) showed in a study that the use of veterinary antibiotics in agriculture 
has been linked to the development of resistance in animals. Evidence suggests that transfer of 
resistance from animals to humans is possible and thus might cause harm to the public health 
(Marshall & Levy, 2011). 
Thailand has a large swine industry, which has improved rapidly during the last decades. 
There is no reliable information about the sales and usage of antibiotics in the country, (UN 
Food and Agriculture Organization (FAO), 2014a). However Tantasuparuk & Kunavongkrit 
(2015) report an increased misuse of antibiotics, vaccines and off-label chemicals. Likewise, 
there is lacking information about the current status on AMR in the country and no 
harmonized AMR-monitoring program on a national level, although it is currently under 
development (FAO, 2014b). 
The purpose of this study was to investigate the occurrence of antimicrobial resistance in 
small-scale swine herds in Khon Kaen Province in the northeast of Thailand, using 
Escherichia coli as indicator bacteria. At the time this study was carried out, another study 
was performed in the same area with the same purpose but with focus on medium-scale farms 
instead (Halje, forthcoming). The purpose was also to compare the findings with data from 
similar studies from Thailand and other countries. According to the World Health 
Organization (2014), only a couple of EU countries, USA and Canada have harmonized 
programs which continuously evaluate the levels of AMR in food producing animals. 
Therefore studies from some of these OECD countries were chosen for comparing the data. 
Pig production 
Throughout the world, the demand for meat is growing. This has led to an increase in the 
number of animals raised and slaughtered each year. Fast growing breeds of pigs with an 
efficient feed conversion rate are thus likely to account for a great share of the livestock 
market in the future. In recent decades the pig production throughout the world has greatly 
been commercialized, with fewer, larger farms raising a greater number of animals. 
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Particularly in the developed world, these large-scale pig operations have more or less 
outrivaled the traditional way of raising pigs, with a few exceptions such as organic pig farms 
and other niche markets (FAO, 2014c). 
In the developing world however, half of the pig population is still kept in small-scale farming 
systems. Raising pigs in these systems can be done with little initial investment and doesn’t 
necessarily require any agricultural land. In addition to providing the families with meat and 
sales income, the pigs also acts as a “bank” where the wealth can be accessed whenever 
money is needed, such as for new investments or health care fees. Furthermore it provides an 
income for women, which helps them strengthen their position in the community, provides 
job opportunities for family members and is overall considered a low risk investment with 
quick returns (FAO, 2014b; FAO, 2011). 
Thailand, along with some of its neighboring countries, has a large swine industry. Since 
Thailand joined the World Trade Organization in 1995, the pig and pork sectors in the country 
have improved fast. In 2013 16.2 million fatteners were produced and the standing population 
of pigs of all ages was 9.51 million. During the last five decades Thailand has seen a shift in 
pig production where the number of small and medium-scale farms has declined in favor of 
larger farms with more animals. Nowadays small and medium-scale farms possess 40% of the 
total pig population, as opposed to 70% before 1970. Small-scale farming is still quite 
common with 94.15% of the total number of households (210,978) raising less than 50 pigs 
each in 2013 (Tantasuparuk & Kunavongkrit, 2015). 
Antimicrobial resistance 
Development of AMR 
Antimicrobial resistance occurs through mutations in the bacteria’s chromosome or via gene 
transfer mechanisms where genetic material is exchanged between bacteria (Furuya & Lowy, 
2006). It is however not a new phenomenon. Most of the antimicrobial drugs that we use 
today are substances that are naturally produced by microorganisms or are modifications of 
these substances. Research shows that some bacteria developed strategies to evade these 
substances millions of years ago. Resistance against synthetic antimicrobials (sulphonamides 
and quinolones) has also emerged since they were introduced and is today present throughout 
the world (Holmes et al., 2015). 
Bell et al. (2014) showed that there is a positive link between human antibiotic consumption 
and the development of antibiotic resistance in humans. Likewise, Chantziaras et al., (2013) 
showed that there are remarkably strong indications of a positive link between veterinary 
antibiotic usage and the development of resistant bacteria in animals, which was also stated by 
the FAO on World Veterinary Day 2012 (FAO, 2015). What is still somewhat under debate 
though is the link between antibiotic use in agriculture and the rise of AMR-bacteria in 
humans and how strong the connection is (Marshall & Levy, 2011). 
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Chang et al. (2014) describe three different mechanisms for how antibiotic use in agriculture 
could be potentially harmful for humans. 1: Direct infection with a pathogen from an animal 
or contaminated food, but without further transmission between humans. 2: A resistant 
microbe infects or colonizes a human like mentioned above, which is then followed by 
transmission from human to human. In some cases humans may become ill. 3: Resistance 
genes arise in agricultural settings, which are then transferred to human pathogens. 
While there are several documented cases of mechanism one and two, it has been more 
difficult to study the effects of mechanism three. This is due to the fact that genes may mutate 
over time while passing through different hosts until they no longer resemble the original 
gene, which makes tracking difficult (Chang et al., 2014; Marshall & Levy, 2011). However, 
despite these difficulties there are documented cases where gene transfer between bacteria 
originating from different species has occurred (Wang et al., 2012; Kruse & Sørum, 1994). 
Mechanisms of AMR 
Different protective mechanisms have evolved that helps the bacteria evade antimicrobial 
drugs, such as preventing the drug from entering the bacteria, increased transportation of the 
drug out of the bacteria (efflux pumps), alteration of the drugs target molecule and producing 
enzymes that modifies or destroys the drug (Holmes et al., 2015). 
Efflux mediated resistance 
Being an important AMR mechanism, drug efflux pumps make it possible for the bacteria to 
evade a drug by transporting it out of the bacteria. It is a key mechanism of AMR, especially 
in Gram-negative bacteria. Drug efflux pumps can be found in bacteria from human, animal, 
plant and environmental origin and the number of pumps described has increased over the 
years. This is a major concern, since multidrug efflux pumps are common and a single pump 
may result in resistance to a number of drugs (Li & Nikaido, 2009). 
Modified target sites 
Different types of antimicrobials have different target sites i.e. penicillin-binding-proteins 
(PBP) in the cell wall (beta-lactam antibiotics), DNA-gyrase/Topoisomerase IV 
(fluoroquinolones), 16S rRNA (aminoglycosides) etc. As these target sites are often involved 
in vital cellular functions, the bacteria cannot simply get rid of them to avoid the 
antimicrobials. Instead, often bacteria modify the target site so that the function remains 
intact, whilst reducing the susceptibility to the antimicrobial (Lambert, 2005). A current 
example of this is Methicillin-resistant Staphylococcus aureus (MRSA). The gene mecA is 
acquired and integrated into the chromosome. When expressed, this gene encodes for a 
penicillin-binding protein 2a (PBP2a), which substitutes other PBPs. This enables the bacteria 
to survive the antibiotic, due to the fact that PBP2a has a lower affinity to beta-lactams than 
regular PBPs (Lowy, 2003).  
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ESBLs – Extended Spectrum Beta-Lactamases 
Extended spectrum beta-lactamases are a group of enzymes produced by different kinds of 
bacteria. The classical definition of ESBLs was set in 1995, as beta-lactamases with the 
ability to hydrolyze and thus inactivate beta-lactam antibiotics of the penicillin group, 
cephalosporins of the third generation as well as monobactams (aztreonam), but which are 
inhibited by clavulanic acid (Lee et al., 2012). This is a definition that is still widely used 
today, but has proved to be somewhat limiting as the knowledge about this group of enzymes 
has improved. There is no clear consensus in the definition of ESBLs and different ways of 
categorizing have been proposed (Lee et al., 2012). Giske et al. (2009) proposed a way to 
categorize the ESBLs into three different groups: Classical ESBLs (as mentioned above), 
miscellaneous ESBLs with a range of different additional traits and lastly ESBLCARBA with the 
ability to hydrolyze carbapenems as well as other beta-lactam antibiotics.  
Bacteria that produce ESBLCARBA have spread quickly throughout the world and have been 
found in both humans and animals (Fischer et al., 2012; WHO, 2014). This is troublesome, 
since there are very few other antibiotics these bacteria are susceptible to and thus treatment 
options are slim (WHO, 2014). 
AMR throughout the world 
Antimicrobial resistance surveillance 
Because of differences in methodology and laboratory procedures throughout the world, 
comparison of data on AMR in food-producing animals between countries is difficult and 
sometimes impossible. According to the WHO there are only a limited number of countries in 
the world today with harmonized AMR surveillance programs in food-producing animals, 
despite the fact that there have been several recommendations over the last decades. Only in 
some EU countries, USA and in Canada there are continuous programs that allow for 
comparison of data. FAO, WHO and the World Organization for Animal Health (OIE) have 
joined together in an effort to combat AMR and have pointed out the need for a more 
harmonized global standard for AMR surveillance in the food chain (WHO, 2014). 
Thailand 
Antimicrobial resistance in livestock is routinely monitored in Thailand, but there is lack of 
harmonization which makes national data difficult to interpret. The National Institute of 
Health, a part of the Department of Livestock Development (DLD) is the institute that 
oversees the AMR-monitoring on a national level. A project to harmonize the AMR-
monitoring across the country is currently in development by the DLD, partly inspired by the 
AMR-monitoring programs from the USA and The European Union. Some problems that 
have to be addressed include lack of harmonization and standardization in AMR-monitoring, 
unregulated usage of antimicrobials, lack of knowledge regarding antibiotic usage on farms 
and untrained personnel (FAO, 2014b). 
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According to a review article released by the FAO (2014b), the antimicrobial resistance in E. 
coli from livestock is well studied in East, South and Southeast Asia and resistance is 
widespread. However, only two studies on E. coli AMR from pigs in Thailand were included 
in this review article and no information about these studies was provided, which hinders 
further evaluation. 
A study in 2008 investigated AMR in E. coli from pigs in the north-eastern parts of Thailand 
(Jiwakanon et al., 2008). Fecal samples were collected between 2003 and 2005 and E. coli 
was isolated from 338 samples. The isolates were tested for susceptibility to 15 types of 
antimicrobial drugs (table 17). Due to translation shortcomings, it is not possible to assess the 
methods of isolation or AMR-testing nor how the samples were collected. 
Another Thai study in 2014 investigated the occurrence of AMR-bacteria with a focus on 
ESBL-producing E. coli in healthy food animals in a northern and eastern province in 
Thailand (Boonyasiri et al., 2014). A total of 400 samples in the form of rectal swabs were 
collected from randomly chosen healthy pigs (age not specified). There was no information 
regarding the sizes of the farms. A disk diffusion method was used to determine the antibiotic 
susceptibility (table 17). 
Europe 
In 2013 the European Commission decided that from 2014 it would become mandatory for 
member states of the European Union to monitor AMR in E. coli, Salmonella and 
Campylobacter jejuni in different food producing animal populations with regular intervals. It 
was also decided that microdilution methods are the standardized way for testing 
antimicrobial susceptibility, followed by the use of Epidemiological cut-off (ECOFF) values 
to interpret the results. These values are provided by the European Committee on 
Antimicrobial Susceptibility Testing (EUCAST) (European Commission 2013/652/EU of 12 
November 2013 on the monitoring and reporting of antimicrobial resistance in zoonotic and 
commensal bacteria). 
A report from the European Food Safety Authority (EFSA) and the European Centre for 
Disease Prevention and Control (ECDC) included 1954 isolates from 10 different member 
states of the European Union. The isolates originated from either fattening pigs or breeding 
animals (seven and one country, respectively) or unspecified (two countries). The majority of 
the isolates were collected as part of the member states’ national AMR monitoring program 
from healthy slaughter pigs at the slaughterhouse. Three countries did not account for 
sampling stage, sample type or sampling context. ECOFFs were used to interpret the 
antimicrobial susceptibility data in accordance with Decision 2013/652/EU (EFSA & ECDC, 
2015).  The results can be seen in table 17. 
Sweden 
The Public Health Agency of Sweden and the National Veterinary Institute each year publish 
a report that includes data regarding consumption of antibiotics and occurrence of antibiotic 
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resistance in humans and animals in Sweden (Swedres-Svarm, 2015). This is a collaboration 
between relevant sectors in Sweden and includes zoonotic pathogens, human clinical isolates, 
animal clinical isolates and, in accordance with the European Commission’s Decision 
2013/652/EU of 12 November 2013, indicator bacteria E. coli and Enterococcus from healthy 
animals. 
The last year Sweden included indicator E. coli from pigs in the report was 2011. Samples in 
the form of colon content were collected from healthy pigs at slaughter. Each sample 
represented a unique herd. The methods used to test the antimicrobial susceptibility of the 
isolates were the same as in this thesis (see Material and methods) (SVARM, 2012). The 
results can be seen in table 16 and 17. 
Denmark 
The Danish Integrated Antimicrobial Resistance Monitoring and Research Programme 
(DANMAP) was established in 1995. The National Food Institute, the National Veterinary 
Institute and Statens Serum Institut are working together to monitor the consumption of 
antimicrobial agents in food animals and humans and the occurrence of antimicrobial 
resistance in bacteria from food animals, meat and humans. Like Sweden the antimicrobial 
resistance monitoring is based on zoonotic bacteria, pathogenic bacteria in humans and 
animals as well as indicator bacteria E. coli and Enterococcus (DANMAP, 2015). 
In the report of 2014, a total of 209 samples in the form of caecal content were collected at 
slaughter plants throughout Denmark. It is unclear whether every sample represented a unique 
herd. A MIC microbroth dilution method in accordance with the European Committee for 
Standardization (2007) was used to test the antimicrobial susceptibility. The results can be 
seen in table 17 (DANMAP, 2015). 
Canada 
The Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) is a 
national program established in 2002. One of its objectives is to monitor trends in 
antimicrobial resistance and antimicrobial use in humans and animals.  
Farms that produced a minimum of 2000 market pigs per year were selected and visited once 
per year. Pooled fecal samples were collected from six pens from pigs close to slaughter 
(>80kg). A total of 1573 samples were collected. The farms were spread out evenly 
throughout the country in proportion to the total number of produced fattening pigs. The 
methods used to test the antimicrobial susceptibility of the isolates were much like the one 
used in this report (see Material and methods). Results from the report of 2013 are shown in 
table 17 (CIPARS, 2015a). 
Antibiotic consumption 
The consumption of antibiotic drugs worldwide is increasing. Van Boeckel, et al., (2015) 
were the first to do a quantitative assessment of the global antibiotic consumption in livestock. 
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In 2010 it was estimated to 63.151 ± 1560 tonnes and is projected to increase with 67% to 
105.596 ± 3605 tonnes by the year 2030. The rising incomes in low- and middle-income 
countries has driven up the demand for meat and therefore intensive production systems that 
are able to  produce meat more efficiently has increased. These systems require antibiotics for 
the animals to stay healthy, and therefore rising incomes in such countries are driving an 
increase in antibiotic consumption in livestock. Indeed, in Brazil, Russia, India, China and 
South Africa (BRICS-countries) the antibiotic consumption in livestock is estimated to 
increase up to 99% in 2030. 
Thailand 
The Department of Livestock Development (DLD) in cooperation with the Food and Drug 
Administration (FDA), Ministry of Public Health regulates the use of veterinary drugs. The 
FDA is responsible for licensing and registration of veterinary drugs and the DLD is 
responsible for surveillance and control of the usage of veterinary drugs and also to list drugs 
and chemicals that are not allowed in food producing animals. Currently all antibiotic use for 
growth promotion in food animals is banned in the country (FAO, 2014b). 
FAO (2014a) reports that usage of antimicrobial drugs based on the personal experiences of 
the farmers without any diagnostic tests are common. This indicates that the usage is poorly 
supervised and that it’s easy for the farmers to obtain antimicrobial drugs. However, no large 
study has been done regarding the antibiotic usage and sales in south-eastern Asia, and so 
there are still uncertainties about the true volumes used. 
Europe 
Growth-promoting antibiotics in the feed are forbidden in the European Union since 2006, 
due to the risk of development of cross-resistance to drugs used in human and veterinary 
medicine (Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 
22 September 2003 on additives for use in animal nutrition).  
A report by European Medicines Agency (EMA) & European Surveillance of Veterinary 
Antimicrobial (ESVAC) (2015) compared 26 different European countries and their sales of 
antimicrobial agents in 2013. The total amount of antimicrobial drugs sold for veterinary use 
in food producing animals in these countries amounted to 8059.2 tonnes of active ingredients. 
The differences in animal demographics play a role in the amount of antimicrobial drugs sold 
in each country. To account for this EMA & ESVAC uses Population Correction Units 
(PCU), which is measured as 1 PCU = 1kg of animal weight. 
An average of 109.7 mg antimicrobial agents/PCU was used in these 26 countries, with huge 
differences between countries. The countries that used the most and least antimicrobial drugs 
were Cyprus and Norway with 425.8 and 3.7 mg/PCU respectively. 
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Sweden 
According to the 2014 Svarm-report, 10,271 kg active substance of antimicrobial drugs was 
reportedly sold for veterinary use in Sweden 2014. Of these 2,883 kg were used in the 
Swedish pig industry. There are, however, some uncertainties regarding these numbers; as the 
Swedish pharmacy market was reregulated some years ago and the data on consumption since 
are assumed to be less complete than before. Three quarters of the antimicrobial drugs sold 
were injectable products. The most commonly sold drug for use in pigs was benzylpenicillin 
with 45% of the total sale. The overall consumption of antimicrobial drugs in pigs has been 
reportedly quite stable during the last five year, however there has been a shift in that the sales 
for products intended for group medication has decrease, while products for individual 
treatment has increased (Swedres-Svarm, 2015). 
According to EMA & ESVAC (2015) the total consumption of antimicrobial agents in food 
producing animals in Sweden in 2013 was 12.6 mg/PCU. This is the third lowest usage of 
antimicrobial drugs in food producing animals among the countries in the report. Only 
Norway and Iceland had a lower rate (3.7 and 5.3 mg/PCU respectively). 
According to EU Regulation No 1831/2003, the use of growth promoting antibiotics in the 
feed is prohibited in Sweden, but a national ban was introduced already in 1986 (Cogliani et 
al., 2011). 
Denmark 
Like in Sweden, growth promoting antibiotics in the feed is prohibited in Denmark according 
to EU Regulation No 1831/2003. This started during the years 1994-1999 when many feed 
administered antimicrobial agents were discontinued by the country’s own initiative. Likewise 
a voluntary ban of the use of cephalosporins in pigs and dairy cattle was introduced more 
recently (DANMAP, 2015). 
According to the Danish report of antimicrobial agents and occurrence of antimicrobial 
resistance in bacteria from food animals, food and humans in Denmark (DANMAP, 2015), 
the total consumption of antimicrobial agents in veterinary medicine in Denmark 2014 was 
amounted to 108.5 tonnes of active ingredients. The use of antimicrobial agents in pigs 
amounted to 82.5 tonnes (76% of the total).   
According to the EMA & ESVAC (2015) report, Denmark used 44.9 mg antimicrobial 
agents/PCU in 2013.   
Canada 
According to the Canadian Integrated Program for Antimicrobial Resistance Surveillance 
(CIPARS), a total of 1.6 million kilograms of antibiotics were distributed for sale for use in 
animals in Canada in 2012. 
   
 
9 
 
In contrast to the European Union, antibiotics in the feed for disease prevention and growth 
promotion are allowed in Canada. Antibiotics in the feed were used by 82% of the farms. The 
most common reasons for the use of antimicrobial use in the feed were for disease prevention 
(49%) or growth promotion (40%). Canada used ca. 160 mg antimicrobial agents/PCU for 
animals in 2012 according to CIPARS (2015b). 
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MATERIAL AND METHODS 
The method used for testing the antimicrobial susceptibility of the isolates in this project is in 
accordance with the standard method established by the European Committee for 
Standardization (CEN) in November 2006 (European Committee for Standardization, 2007). 
Farms and logistics 
A total of 25 farms located in the surroundings of Khon Kaen were included in the study. The 
inclusion criterion was that each farm had a maximum of 20 sows. With the help of the local 
supervisor, the farms were selected from a list provided by the local veterinary service officer. 
The local supervisor also arranged for transportation in university vans and for 5th or 6th year 
Thai veterinary students to ride along to act as translators. 
Questionnaire 
At every farm the person responsible for the pigs was asked to fill in a questionnaire with 
questions about the farm, husbandry, antibiotic usage, vaccination regimes etc. (Appendix 1). 
This was to help gain insight in pig-farming in Thailand and the possibility to identify 
possible protective or risk-factors for AMR. 
Sample collecting 
The samples were collected during the weekends over the course of 4 weeks in September. 
On each farm, three samples were collected in the form of rectal swabs from three randomly 
picked healthy sows. The swabs were performed by either the author or a colleague (Halje, 
forthcoming). If a farm did not have three healthy sows, as many samples were taken as there 
were healthy sows. A total of 69 samples were collected. The swabs were put in tubes 
containing Amie’s transport medium for the transport back to the laboratory at the Veterinary 
Faculty, Khon Kaen University. The duration of the transport was between 1 and 6 hours. 
Tubes were stored for a maximum of 48 hours at 2-4°C before work in the laboratory began. 
AMR detection 
To isolate E. coli bacteria each swab was streaked on a MacConkey agar plate and incubated 
in 44°C overnight. Then colonies that morphologically looked like E. coli were sub-cultured 
individually on blood agar plates and incubated in 37°C overnight. Finally the resulting 
bacterial growth was incubated in Motility-Indole-Lysine (MIL) medium in 37°C overnight. 
Kovac’s reagent was added to test the isolate for production of tryptophanase (indole-test). A 
positive indole test was used to confirm that it was an isolate of E. coli. Only one confirmed 
E. coli isolate per animal was included in the antimicrobial susceptibility testing.  
To test the antimicrobial susceptibility of the isolates, the minimum inhibitory concentrations 
(MICs) were determined using a broth microdilution method (European Committee for 
Standardization, 2007). VetMIC GN-mo panels (Version 2015-07) manufactured by the 
Swedish National Veterinary Institute were brought along to Thailand. Each VetMIC panel 
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consists of 8 x 12 wells containing different dried antibiotics in serial twofold dilutions. In 
total, 14 different antibiotics are included (Figure 1). 
 
Figure 1: The VetMIC GN-mo panel used for antimicrobial susceptibility. In each column the 
concentration of the antibiotic increases twofold for each well in the direction H to A. The wells 
containing meropenem later proved to be faulty and wasn’t included in the study. 
The broth used was sterile cation adjusted Mueller Hinton broth (CAMHB) with pH 7.2-7.4. 
A plastic loop was used to collect 3-5 colonies of E. coli from a blood agar plate. These were 
then suspended in 5 ml CAMHB and incubated in 37°C for 1 h 50 min to reach a desired 
concentration of 108 CFU/ml. To confirm the concentration the suspension was visually 
assessed to have a turbidity of 0.5 McFarland, after which 10 µl of the suspension was 
transferred to 10 ml CAMHB to obtain a final inoculum density of approximately 5 x 105 
CFU/ml. The density was regularly verified by taking 10 µl of the inoculum and diluting it in 
10 ml 0.9% saline. Of this dilution 100 µl was then spread evenly on a blood agar plate and 
incubated in 37°C overnight. The resulting growth was then checked to be 10-100 CFU. 
Each well was filled with 50 µl of the inoculum, sealed with plastic film and incubated in 
36°C for 17 hours. The wells were then inspected and the lowest concentration inhibiting 
visible growth was read as the MIC (Swedres-Svarm, 2015). 
To secure the quality of the MIC tests, control stain E. coli CCUG 17620 (ATCC 25922) was 
included in every round of tests.   
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Interpreting the MICs 
Epidemiological cut-off values (ECOFFs) from the European Committee on Antimicrobial 
Susceptibility Testing (EUCAST) were used to interpret the MICs of the antibiotics. An 
isolate is classified as resistant if the MIC exceeds the ECOFF (http://www.eucast.org).  
ECOFFs are used to find isolates with acquired reduced susceptibility, but do not provide 
information whether or not an isolate will respond to antimicrobial treatment. An isolate that 
is classified as resistant in this report is therefore not necessarily clinically resistant. 
Multiresistance 
In this thesis the definition of multiresistance is in accordance with the definition proposed by 
Magiorakos et al. (2012). In their paper, multiresistance is defined as an isolate with acquired 
resistance against three or more different classes of antibiotics. This is also the way 
multiresistance is defined in the Swedish Veterinary Antibiotic Resistance Monitoring 
(Svarm) report (Swedres-Svarm, 2015). 
Statistical analyses 
Statistical analyses were conducted in SAS software 9.4 (SAS Institute Inc., Cary, NC). 
Descriptive statistics were calculated to define farm characteristics. Kruskal-Wallis test was 
used to investigate differences in number of sows and farm type. To investigate associations 
between management factors and antibiotic use and resistance, univariable logistic regression 
and Fisher’s exact test were used. The statistical significance level was defined as a two-tailed 
P-value ≤0.05. 
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RESULTS 
Farm locations 
The farms were located in a radius of ca. 20 kilometers from Khon Kaen City in Khon Kaen 
Province, north-eastern Thailand. The locations can be seen in figure 2. 
 
Figure 2: Shows the locations of the farms visited in Khon Kaen Province. Photo: Gunilla 
Ström 
Farm characteristics and antibiotic use 
Housing 
The most common type of farm (60%) was the “farrow-to-finish” type, i.e. a farm that raised 
pigs from farrowing until they are ready for slaughter. A lesser number of farms (28%) were 
identified as breeding farms and sold their piglets after weaning, while only a small 
proportion of farms combined these practices (Table 1). 
Table 1: The different types of farms 
Type of farm % n=25 
Farrow-to finish 60% 15 
Breedning 28% 7 
Combination of the two 12% 3 
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The number of sows on the farms varied from one to nineteen, with a median of five sows (5 
and 95% percentiles: 1.2 and 11.8) per farm. The median number of sows on farrow-to-finish 
farms was four, and for breeding farms ten, but the difference was not statistically significant. 
The farms acquired the sows either through breeding their own, or by buying from other 
farms (table 2). Some farms acquired their sows both by breeding their own and buying from 
other farms. Farms that kept more sows were more likely to breed their own (P = 0.019). 
 
 
 
 
  
There were no free-roaming pigs of any age group on any of the farms (n=25). Different 
means of confining the sows were used and are shown in table 3. The enclosures ranged from 
conventional metal crates that restricted the sows’ ability to move except for lying down or 
standing up, to larger pens where the sows were free to move around. Which type of 
confinement that was used, differed somewhat between nursing and gestation sows, in that 
nursing sows were more likely to be fully confined in a metal crate than the gestation sows.  
Table 3: The different means of confining the sows 
 Nursing sows confinement % n=24 Gestation sow confinement % n=22 
small metal crate 50.0% 12 small metal crate 36.4% 8 
pen ≤3x3m 45.8% 11 pen ≤3x3m 59.1% 13 
pen >3x3m 4.2% 1 pen >3x3m 4.5% 1 
 
No types of cooling systems were used on the farms, instead all of the farms (n=25) used so 
called open-air systems, which allows the wind to blow through the enclosures. This also 
allows for birds and other animals to enter the enclosures and come in contact with the pigs. 
All the farms (n=24) kept the sows on floors that were made of solid concrete except one that 
used dirt floors. Finally, all the farms (n=25) practiced a “continuous flow system” of sows in 
the farrowing units.  
Management and antibiotic usage 
The cleaning intervals at the farms are presented in table 4. About 50% of the farms reported 
that they clean the floors daily.  
  
Table 2: The different ways the farms acquired the sows 
  Where do you get your sows? % n=25 
Breed your own 28% 7 
From another farm in the district 32% 8 
From another farm outside the district 16% 4 
Breed your own and buy from another farm in the district 16% 4 
Breed your own and buy from another farm outside the district 8% 2 
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Table 4: The cleaning intervals in the pens 
  How often are faeces removed from the floor? % n=25 
1/day 24% 6 
2/day 28% 7 
1-4 times per week 12% 3 
More seldom than once per week 0% 0 
Never 36% 9 
 
All the farms reported that they vaccinated their sows, but only 17 of the farms were able to 
tell what diseases they vaccinated against. All of these farms vaccinated against classical 
swine fever. Table 5 shows the list of vaccines used and how commonly used these were. 
Table 5. The table shows the number and proportion of farms that 
used different vaccines (n=17) 
Vaccine Number of farms Percentage 
Classical swine fever 17 100.0% 
Erysipelothrix/parvo combination 5 29.4% 
Mycoplasma 5 29.4% 
Rabies 8 47.1% 
PRRS 3 17.7% 
Aujeszky's disease 2 11.8% 
 
Antibiotics for injection were reportedly used on all the farms, although only 21 of the farms 
were able to tell what kinds of antibiotics they used (Table 6). The most common kind used 
for injection was enrofloxacin, which was used on 44% of the farms. Amoxicillin was used on 
32% of the farms, followed by kanamycin which was used on 20% of the farms. 
Only one farm reported using antibiotics in the feed to treat sick animals. Amoxicillin, 
sulfonamide and oxytetracycline were used, but the farmer was unable to specify the amounts 
that were used. 
Table 6. The table shows the number and proportion of farms that uses a 
specific antibiotic (n= 21) 
Antibiotic Number of farms Percentage 
Amoxicillin 8 32% 
Enrofloxacin 11 44% 
Penicillin/streptomycin combination 4 16% 
Kanamycin 5 20% 
Florfenicol 1 4% 
Oxytetracycline 1 4% 
Gentamicin 1 4% 
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Eight farms reported using antibiotics as a routine after farrowing. The sow would get one or 
more injection to prevent illness during the nursing period. This was not a question included 
in the questionnaire however, so there is no data regarding the farms that did not specify this 
on their own initiative. 
When it came to deciding about how and when to give antibiotics to the sows, the most 
common way was for the farmer to decide (see table 7). This was reportedly the case in 64% 
of the farms, while 32% reported that a veterinarian decided. One farm reported enlisting the 
help of the owner of a neighboring farm to decide about when to give antibiotics. 
There was no significant difference in the resistance pattern depending on whether the owner 
or veterinarian decided about the antibiotic treatments.  
Table 7: Shows who decides about the antibiotic treatments 
  Who decides about when and how to give antibiotics if a sow gets ill? % n=25 
Veterinarian 32% 8 
Owner of the farm 64% 16 
Other person 4% 1 
 
The most common way to get access to antibiotics was to buy it from a local store or 
pharmacy, with 60% of the farms acquiring their antibiotics this way. The second most 
common method was to buy directly from a veterinarian, which 32% of the farms did (Table 
8). 
There was no significant difference in the resistance pattern depending on whether the farmer 
bought the antibiotics in a local store/pharmacy or directly from the veterinarian. 
Table 8: Shows the different ways farms got access to antibiotics 
How do you get access to the antibiotics/where do you buy it? % n=25 
Buy from veterinarian 32% 8 
Buy from local store/pharmacy 60% 15 
Buy from contract farm 4% 1 
Buy from other place 4% 1 
 
The majority of the farmers (60%) reported that they treat a sow on the farm two to three 
times per year on average (table 9). Only 15% reported that they treat a sow more often than 
three times per year.   
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Table 9: Shows how often a sow was treated on the farm    
How often on average per year is a sow treated intramuscularly? % n=20 
1 /year 25% 5 
2-3/year 60% 12 
>3/year 15% 3 
 
Laboratory results - antimicrobial susceptibility 
Escherichia coli was successfully isolated from all 69 samples. The distribution of MICs and 
percent resistance are shown in table 14. To see the individual resistance pattern for each 
farm, see table 15. 
All of the farms produced an isolate that showed resistance against at least one type of 
antibiotic (Table 15). Resistance against tetracycline (75.3% of the isolates), ampicillin 
(69.6%) and sulfamethoxazole (60.8%) were the most common, followed by ciprofloxacin 
(40.5%) and chloramphenicol (39.1%) 
Multiresistance could be seen in 69.5% of the isolates, while 10.1% of the isolates were 
susceptible to all types of antibiotics (Table 10).  
Table 10. Quantity and proportion of isolates resistant to none or all of 
the tested antibiotic classes 
Resistance No. of isolates Percentage 
Susceptible to all 7 10.1% 
Resistant against 1-2 classes 14 20.3% 
Resistant against 3-5 classes 39 56.5% 
Resistant against >5 classes 9 13.0% 
 
Of the multiresistant isolates, 63.3% shared resistance to the three most common antibiotics 
tetracycline, ampicillin and sulfamethoxazole. This and the individual isolates proportion of 
resistance against these antibiotics are shown in table 11. 
Table 11. Quantity and proportion of the multiresistant isolates (n=48) 
resistant to ampicillin, tetracycline and sulfamethoxazole 
Antibiotics No. of isolates Percentage 
Am 45 91.8% 
Tc 44 89.8% 
Su 40 81.6% 
Am + Tc + Su 31 63.3% 
 
One isolate showed the characteristics of a possible ESBL-producing bacterium in that it 
showed resistance to ampicillin, cefotaxime and ceftazidime. The MICs are shown in table 12. 
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Table 12. The MICs (mg/L) for the suspected ESBL-producing isolate 
Antibiotics Am Ci Nal Gm Sm Tc Ff Cs Su Trim Cm Mp Ctx Caz 
Suspected ESBL isolate >128 >1 >128 1 8 64 8 2 ≤8 0.5 >32 0.06 >2 >4 
 
In some cases, farms that showed resistance against one type of antibiotic had a tendency to 
also show resistance against another type (Table 13). 
Table 13: Farms resistant to antibiotic 1 had a tendency to 
also show resistance to antibiotic 2 
Antibiotic 1 Antibiotic 2 P-value 
Sulfamethoxazole Trimetoprim P = 0.057  
Ciprofloxacin Sulfamethoxazole P = 0.024 
Ciprofloxacin Trimethoprim P = 0.081  
Ampicillin Tetracycline P = 0.120 
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Table 14: Resistance and distributions of MIC for the bacteria tested (n=69). Vertical lines mark the ECOFFs. White fields denote range of dilutions tested for each 
substance. MICs above the tested range are shown as the concentration closest above the tested range (in the blue field). MICs equal to or lower than the lowest 
concentration tested are shown as the lowest tested concentration 
Antimicrobial 
agent 
Resistance Distributions  (%) of MICs (mg/L) 
(%) ≤0.008 0.016 0.03 0.06 0.12 0.25 0.5 1 2 4 8 16 32 64 128 256 512 1024 >1024 
Ampicillin 69.6               8.7 20.3 1.4 
    
2.9 66.7       
Ciprofloxacin 40.5 
 
1.4 18.8 39.1 2.9 5.8 10.1 8.7 13.0                     
Nalidixic acid 20.2               
 
8.7 46.4 20.3 4.3 7.2 
 
2.9 10.1       
Gentamicin 11.4           7.2 36.2 34.8 10.1 4.3 
 
1.4 1.4 4.3           
Streptomycin 37.6                 7.2 17.4 21.7 15.9 10.1 1.4 14.5 2.9 8.7     
Tetracycline 75.3               2.9 11.6 7.2 2.9 8.7 30.4 30.4 5.8         
Florfenicol 14.5                   5.8 62.3 17.4 
 
14.5           
Colistine 0.0             73.9 14.5 11.6 
 
                  
Sulfamethoxazole 60.8             
    
26.1 10.1 2.9 
   
1.4 
 
59.4 
Trimethoprim 42.0         
 
4.3 36.2 15.9 1.4
   
42.0             
Chloramphenicol 39.1                   20.3 37.7 2.9 21.7 17.4           
Cefotaxime 1.4     15.9 66.7 14.5 1.4 
   
1.4                   
Ceftazidime 4.3       
 
13.0 66.7 15.9 2.9
  
1.4                 
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Table 15: The individual resistance patterns for the farms. Each letter represents one isolate 
     Farm No. Am Ci Nal Gm Sm Tc Ff Cs Su Trim Cm Ctx Caz 
     1 RSS RSS SSS SSS SSS RRR SSS SSS RSR SSR SSS SSS SSS   Every sample from the farm 
were resistant against this type 
of antibiotic 2 SSS RRS RSS RSS SSS RSS RSS SSS RSS RSS RSS SSS SSS 
 3 RSS RSS SSS SSS RSS RRR RSS SSS RRS SRS RRS SSS SSS   Every sample from the farm 
were susceptible against this 
type of antibiotic 4 RRS RRS RRS SRS RSS RRR RSS SSS RRR RSR RSS SSS SSS 
 5 RRR SRS SSS SSS SSR RRR SSS SSS RRR RSR SSR SSS SSS   The samples from the farm 
were different in their resistance 
pattern 6 RRR SRR SSS SSS RSS SRR RSS SSS RRR RSR RSR SSS SSS 
 7 RRR RRR RRS RSS RRR RSR SSS SSS RRS RSS RSS SSS SSS 
     8 SRR SRR SRS SSS SRS SRR SSS SSS SRR SRR SRR SSS SSS 
     9 RRR SSS SSS SSS SRS RRR SSS SSS RSS SSS SSS SSS SSS 
     10 RRR RSS RSS SSS SSS SSR SSS SSS SRR SSR SRR SSS SSS 
     11 SSS SSS SSS SSS SRR SSS SSS SSS SSS SSR SSS SSS SSS 
     12 RRR SSS SSS SSS RSS RRR SSR SSS RRS RRS SRR SSS SSS 
     13 R R S S R R S S R R R S S 
     14 RSR SSR SSS SSS RSS RRR SSS SSS SSR SSS SSS SSS SSR 
     15 RR SR SR SS RS RR SS SSS RR RR SS SS SS 
     16 RRS SSS SSS SRS SSS SRS SRS SSS SSS SSS SRS SSS SSS 
     17 RSS SSS SSS SSS SRS RRR SSS SSS RRS RRS RRS SSS SSS 
     18 RRR RRR SSS SSS SSR RRR SSS SSS RSR RSS RSS SSS SSS 
     19 RRS SSS SSS SRS RRS SRS SSS SSS RSS RSS SSS SSS SSS 
     20 RSR RSR RSS SSR RSR RSR SSS SSS RSR SSR SSR SSS SSS 
     21 RRR RRR RRR RSS RRR RRR RSS SSS RRR RRS RSR SSS SSS 
     22 R R R R S R R SSS R R R S S 
     23 RRR RRS SRS SSS RSR RRR SSR SSS RSR SSR RRR SRS SRS 
     24 SRR SSS SSS SSS SSS RRS SRS SSS RSR RSS SRS SSS SSR 
     25 SS SS SS SS SS SR SS SSS SS SS SS SS SS 
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DISCUSSION 
The results indicate that AMR is common in small-scale pig farms in north-eastern Thailand. 
There may be many different reasons for this, of which some are discussed below. 
Although only one farm (4%) reported treating the sows with oxytetracycline, as many as 
75.3% of the isolates showed resistance against tetracycline. The same can also be seen when 
looking at sulfamethoxazole and trimethoprim, where no farms reported any usage of these 
antibiotics but the resistance rates were 60.9 and 42.0% respectively. A reason for this could 
perhaps be that these antibiotics were formerly used in great volumes in pig farms throughout 
the area and have become obsolete due to the fact that they are now less useful because of 
resistance against the drugs. The resistance mechanisms may still be present though, which 
could explain this resistance pattern. Another explanation could be that resistance is present 
due to co-selection, where the usage of one type of antibiotic facilitates the development of 
resistance against other types.  
A similarly high resistance rate can be seen in ampicillin (69.6% of the isolates). Amoxicillin, 
which is in the same family of antibiotics as ampicillin, is however still in use in 32% of the 
farms. It would be interesting to perform a study similar to this one within a couple of years to 
see if the usage of amoxicillin has changed. 
A majority of the farms acquired their antibiotics from local stores and decided themselves 
when to treat the animals without any consultation from a veterinarian. This could perhaps be 
one reason why the resistance rate is higher in Thailand than in some of the OECD countries 
where antimicrobial drugs require a prescription from a veterinarian or are regulated in more 
strict ways (table 17). The ease of which these drugs are acquired might increase the 
consumption and thereby promote the development of AMR. 
Additional factors that might increase the need for and use of antimicrobial drugs are the 
housing system and flow system of the farms. All farms utilized an open air system and a 
continuous flow system in the farrowing units. The open air system allows the wind to blow 
through the enclosures. This also allows birds and other animals, but also pathogens to come 
in contact with the pigs. A continuous flow system in the farrowing units makes adequate 
cleaning and disinfection difficult and facilitates disease spread between animals since sows 
continuously are mixed together. The hot and humid climate in Thailand also increases the 
risks for bacterial and fungal diseases to spread. All of this may result in increased usage of 
antimicrobial drugs. 
The results from seven studies on AMR from different countries throughout the world are 
presented in table 17 together with the results from this study. These studies show some 
differences in the antimicrobial resistance pattern. However, one must not compare the data 
from these studies without taking into consideration the differences in methodology from the 
different studies. 
The studies from Sweden (SVARM, 2012), Europe (ECDC, 2014), Denmark (DANMAP, 
2015) and Halje (forthcoming) are comparable to this one, due to the fact that they all follow 
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the standardized methodology of antimicrobial susceptibility testing (European Committee for 
Standardization, 2007) and ECOFFs provided by EUCAST to interpret the results. Worth 
noting is that the results from EFSA & ECDC (2015) are the combined results from ten 
different member states. The level of resistance between different member states may differ. 
The Canadian results (CIPARS) must be interpreted with the knowledge that the breakpoints 
used to determine resistance were in general higher than the ECOFFs (CIPARS, 2015a). This 
means that an isolate classified as resistant in this study, might not be so in CIPARS. 
Therefore the percentage of resistance might be higher than presented in table 17. 
Likewise, one must interpret the results from the two Thai studies (Jiwakanon et al., 2008; 
Boonyasiri et al., 2014) with caution as there is no information regarding the methods used to 
interpret the AMR data.  
Even so, there are remarkable differences in the antimicrobial resistance patterns. Sweden had 
the lowest rate of resistance in virtually all the tested antibiotics except chloramphenicol, 
ciprofloxacin and nalidixic acid, where Denmark had a lower resistance rate (Table 17). The 
resistance rates were generally higher in all the Thai studies than in the rest of the studies 
(Table 17). Likewise, the levels of multiresistance in this report and Halje (forthcoming) (69.5 
and 95.1%, respectively) were higher than what was reported in Sweden (13%) (Table 16). 
Table 16: Resistance to different numbers of antibiotic classes. Numbers taken from SVARM, 2012; 
Halje (forthcoming) and this report 
Area (Numbers of isolates tested)  
Percentage of isolates resistant to different 
numbers of antibiotic classes 
 0 1 2 ≥3 
Sweden (167) 72.0 9.0 5.0 13.0 
Thailand 2015 (Halje) (81) 2.5 0.0 2.5 95.1 
Thailand 2015 (Karlsson) (69) 10.1 11.6 8.7 69.5 
 
When comparing this study and the Halje study (small-scale farms vs medium-scale industrial 
farms in Thailand), the level of resistance was higher in all types of antibiotics in the Halje 
study, except for gentamicin and Cefotaxime. This could possibly be because of the 
differences in antibiotic usage between the two types of farms. It is reasonable to believe that 
the antibiotic usage on medium-scale industrial farms is more organized and continuous than 
it is in smaller backyard farms. 
Boonyasiri et al. (2014) reported on high levels of ESBL-producing E. coli; 80.2% from the 
northern Thai province and 64.7% from the eastern province. This is in contrast to the 
findings in this study, where only one possible ESBL-isolate was found, and the rest of the 
studies. Here as well it is reasonable to believe that the unregulated usage of antibiotics in 
Thai farms is the factor behind these findings. A possible reason for the big difference in the 
occurrence of ESBL-producing E. coli between the Boonyasiri study and this one is that the 
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methods differed. The former used agar plates containing cephalosporins when isolating the 
bacteria, which selects for the growth of ESBL-producing bacteria. This makes the 
comparison between the two studies impossible when it comes to the occurrence of ESBL-
producing E. coli.  
There is a difference in the usage of antibiotic drugs in livestock between the different 
countries and this might reflect the resistance pattern. Since Sweden has very strict 
regulations and practices on the use of antibiotic drugs and Thailand a loosely regulated one, 
it is maybe not that difficult to accept that Sweden has the lowest resistance rate and Thailand 
the highest. 
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Table 17: Antimicrobial susceptibility in pigs in Canada, Europe, Denmark, Sweden and Thailand. Numbers taken from 
CIPARS,2015c*; EFSA & ECDC, 2015***; DANMAP, 2015; SVARM,2012;  Jiwakanon et al., 2008**; Boonyasiri et al.,2014**; 
Halje (forthcoming) and this report 
 
 
Percent of isolate resistant from different countries. * The breakpoints used in CIPARS are 
in general higher than the ECOFFs. 
Thus, the level of resistance might in 
fact be higher than shown here, if one 
were to use ECOFFs instead. 
 
**These results must be interpreted 
with caution, since there is no 
information regarding the methods 
used to interpret the AMR data. 
 
***The resistance level presented 
here is the combined results from 10 
different member states. The 
individual level of resistance differs 
between countries. 
Area (number of isolates 
tested) Aminoglycosides Penicillins Cephalosporines 
Folate pathway 
inhibitors  
  Gm Km Sm Ak Am Ctr Cox Cef Cti Ctx Caz TrSu Tm Sua 
Canada, 2013 (1573) 1.0 12.5 34.0   31.1 1.4 1.1   1.1     13.4   45.4 
Europe, 2013 (1954) 1.8   47.8   30.3   
   
1.3 
 
    42.1 
Denmark, 2013 (209) 1.0       33.0   
   
0.0 0.0   24.0 34.0 
Sweden, 2011 (167) 1.0 1.0 16.0   13.0   
   
<1.0 
 
  11.0 17.0 
Thailand, 2008 (338) 30.8 40.8 66.3   84.5   
 
2.0 
 
0.5 
 
85.2 87.3   
Thailand, 2014 North (330) 58.6     0.6   59.7 2.4 
    
      
Thailand, 2014 East (70) 55.4     12.9   57.1 35.7 
    
      
Thailand, 2015 (Halje) (81) 7.4   76.5   85.2         1.2 3.7   70.4 84.0 
Thailand, 2015 (Karlsson) (69) 11.4   37.6   69.6         1.4 4.3   42.0 60.8 
 
  
  
 
  Area (number of isolates 
tested) Amphenicols Polymyxins Quinolones Tetracycline 
Antibiotics: 
Gm Gantamicin 
 
TrSu Trimethoprim-sulfamethoxazole 
  Cm Ff Cs Ci Nal Tc Km Kanamycin  Tm Trimethoprim    
Canada, 2013 (1573) 20.3       0.3 75.4 Sm Streptomycin  Sua Sulfonamides  
Europe, 2013 (1954) 14.7     6.1 3.8 52.8 Ak Amikacid  Cm Chloramphenicol  
Denmark, 2013 (209) 2.0   0.0 0.0 0.0 37 Am Ampicillin  Ff Florfenicol  
Sweden, 2011 (167) 4.0 0.0 0.0 2.0 2.0 8.0 Ctr Ceftriaxone   Cs Colistin  
Thailand, 2008 (338)     3.5 26.8 37.6 97.9 Cox Cefoxitin   Ci Ciprofloxacin 
Thailand, 2014 North (330)     0.3–2.9 32.7 12.1 62.4 Cef Cefuroxine  Nal Nalidixic acid  
Thailand. 2014 East (70)     0.3–2.9 71.4 51.4 84.3 Cti Ceftiofur   Tc Tetracycline 
Thailand, 2015 (Halje) (81) 58.0 2.4 0.0 48.1 30.8 86.3 Ctx Cefotaxime 
  Thailand, 2015 (Karlsson) (69) 39.1 14.5 0.0 40.5 20.0 75.3 Caz Ceftazidime 
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To find suitable farms sometimes proved to be difficult due to uncertain information about the 
number of sows and precise geographical location of the farms. In addition, poor 
communication options made direct contact with the farmers difficult. The translator often 
had to make contact with the head of the village, who then provided the information needed to 
find the farms. 
In Decision 2003/652/EU there are instructions on the sampling strategy for the harmonised 
AMR monitoring in EU. These instructions specify that samples are to be taken from 
fattening pigs, since they are closest to the consumer in the food chain (EFSA, 2014). The 
decision to collect samples from sows instead of fattening pigs was because at small-scale 
farms there might not always be fattening pigs available for sampling. 
The answers from question number 10b “How often are the floors washed with 
water/soap/disinfection?” (Appendix 1) were excluded from this report, due to the fact that 
the question was badly phrased. The answers given did not differentiate between cleaning the 
floors using only water, using only disinfectant or a combination of the two, as was intended 
when asking the question. 
Statistical analyses were made to find possible risk factors for AMR and investigate other 
associations between management factors, antibiotic use and AMR. However, since only 25 
farms were visited, these statistical analyses were difficult to perform due to the small number 
of observations and those made must therefore be considered to lack in statistical power. 
CONCLUSIONS 
Antimicrobial resistance in small-scale swineherds in north-eastern Thailand seems to be 
common. Even though a number of studies have been done on the subject, there is still a lot of 
uncertainty on the full width of the problem. A standardized and harmonized program similar 
to the ones in Europe and Canada is needed to map AMR throughout the country and be able 
to compare the data with other countries. A program like this is currently in development by 
the Thai DLD and will hopefully be active soon. Furthermore the usage of antimicrobial drugs 
in the country must be surveyed and regulated to avoid the problem with AMR to grow even 
further.  
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Appendix 1 
 
 
Questionnaire – small farms 
Name of the owner of the farm: 
 
 
GPS-coordinations:  
 
Working position of person answering the 
questionnaire: 
 
 
Type of farm (farrow-to-finish/breeding/other) 
 
Number of sows: Number of weaned pigs: 
 
1. From where do you get your sows? 
a. Breed our own 
b. From another farm in the district 
c. From another farm, not in the same district 
d. Other: 
Questions about antibiotic usage 
2. Do you give antibiotics in the feed? 
Yes/No 
3. What kind of antibiotics do you use? 
a. In the daily feed for nursing sows: 
 
 
b. In the daily feed for gestation sows: 
 
 
 
 
c. For injections in sows that are ill (including treatment protocol): 
Appendix 1 
   
 
 
 
Type of antibiotic                                                        Number of days in treatment 
 
 
 
 
 
 
d. By feed to sows that are ill (including treatment protocol): 
Type of antibiotic                                                        Number of days in treatment 
 
 
 
 
4. At how many occasions (on avarage) per year is a sow treated (p.o. respectively i.m.) 
Per os : 
Intramuscular : 
5. How do you get access to the antibiotics? Where do you buy it? 
a. Buy from veterinarian 
b. Buy from local store/pharmacy 
c. Buy from contract farms 
d. Other: 
6. How much feed do the sows get per day and how much antibiotics does the feed contain? 
 
  How often? How much? 
Antibiotic 
concentration? 
Nursing 
  Times/d Kg/d   
Gestation       
 Times/d Kg/d  
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7. Who decides about when and how to give antibiotics if a sow gets ill?  
a. Veterinarian 
b. Small doctor/technician  
c. Owner of the farm 
d. Worker on the farm 
e. Other person:  
8. Do you vaccinate the pigs? Against which diseases? 
Yes/No 
 
 
Questions regarding husbandry 
9. Do you use a “continuous flow system” or an “all-in, all-out system” in the farrowing units? 
 
 
10. How often are the floors  
a. cleaned from faeces with a broom or something similar? 
b. washed with water/soap/disinfection? 
a. 
 
b. 
 
11. What type of disinfection do you use for cleaning? 
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For us to fill in 
12. Type of cooling system? (Evaporation/conventional (open air) system) 
a. Evaporation 
b. Conventional (open air) 
c. Other:  
13. What type of floor do the sows have? 
 
14. Are the sows confined? What type of confinement? 
 
15. Density of farms in the village? (For us, look at the map) 
 
 
 
